Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Investment
141 Articles Available
1
6
Can't find what you're looking for? Try our
advanced search
.
Financing
ADC Therapeutics Announces Final Close of Series E Financing Expansion
PR-M07-19-NI-029
Financing
IGM Biosciences Announces $102 Million Series C Financing to Advance its IgM Antibody Platform and Pipeline
PR-M07-19-NI-028
Funding
Esperion Raises an Additional $200 Million
PAO-M07-19-NI-015
Funding
Esperion and Oberland Capital Announce $200 Million Funding Agreement
PR-M07-19-NI-007
Investment
Mirum Pharmaceuticals Files for IPO
PAO-M07-19-NI-001
IPO
BridgeBio Pharma Announces Pricing of Its Initial Public Offering
PR-M06-19-NI-060
Drug Development
Mill Creek Life Sciences Receives Grant for Development of Dendritic Cell Vaccine
PR-M06-19-NI-037
Series B Financing
Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform
PR-M06-19-NI-022
Series A Funding
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Health
PR-M06-19-NI-016
Series B Financing
Whole Biome Raises $35 Million in Series B Financing
PAO-M06-19-NI-002
Financing
Thrive Earlier Detection Gets Funding from Third Rock to Develop Cancer Detection Tech
PAO-M06-19-NI-001
Investment
Boehringer Ingelheim Investing in Mexico
PAO-M05-19-NI-033
Business Development
Running a CDMO Business is Hard – So Now Let’s Talk about Value Creation
PAP-Q2-2019-CL-015
Series A Financing
Syncona founds Quell Therapeutics with £35 million Series A Financing
PR-M05-19-NI-063
Financing
Schrödinger Announces Close of Latest Financing, Raising a Total of $110 Million
PR-M05-19-NI-062
Funding
Philogen Raises $70 Million
PAO-M05-19-NI-019
Financing
Actuate Therapeutics Completes $21.7 Million Series B Financing
PR-M05-19-NI-061
Financing
KNOW Bio Announces Closing of $30 Million in Equity Financing
PR-M05-19-NI-048
Investment
Fengate Exceeds Fundraising Target and Closes Core Infrastructure Fund III with $1.1 Billion in Capital Commitments
PR-M05-19-NI-046
Investment
LeapFrog Breaks Impact Investing Record, with $700M Emerging Markets Fund
PR-M05-19-NI-043
Investment
Bayer Invests $150 Million to Build New Cell Culture Technology Center in Berkeley to Spur Innovation of Biotech Therapies
PR-M05-19-NI-040
Funding
Elligo Health Research Raises $20M to Connect More Physicians and Their Patients to Clinical Research as a Care Option
PR-M05-19-NI-033
Financing
KIYATEC Announces $3 Million Initial Closing of Series B2 Preferred Stock Financing and New Investor LabCorp
PR-M05-19-NI-031
Earnings
Invitae Reports 47% Growth in Quarterly Revenue and Volume Year-Over-Year
PR-M05-19-NI-026
1
6
»
